Last update Jan. 29, 2017
Compatible
We do not have alternatives for クロモグリク酸ナトリウム since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
クロモグリク酸ナトリウム is Sodium Cromoglicate in Japanese.
Is written in other languages:クロモグリク酸ナトリウム is also known as
クロモグリク酸ナトリウム belongs to these groups or families:
Main tradenames from several countries containing クロモグリク酸ナトリウム in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | <1 oral. 7-10 inhal. 0.03 oft. | % |
Molecular weight | 512 | daltons |
Protein Binding | 65 | % |
Tmax | 0.2 | hours |
T½ | 1.3 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
It is administered by inhalation for the prevention of asthma and atopic rhinitis, orally for food allergies and topically on dermatologic and ophthalmologic conditions.
At latest update relevant published data on excretion into breast milk were not found.
There is a consensus among experts and scientific societies on considering Sodium Chromoglycate as compatible while breastfeeding (Nelson 2001, National Asthma Education 2004, Powrie 2006) because of a minimal absorption and low plasma levels appearing in the mother (AEMPS 2013, Davis 2015).
The small dose used and low plasma absorption of most inhaled preparations (either buccal or nasal), topically apply as ophthalmologic or dermatologic preparations, make it unlikely any passage in a significant amount into breastmilk.
WHO List of Essential Medicines 2002: compatible while breastfeeding.